Skip to main content

Advertisement

Table 1 Selected patient, tumor and treatment characteristics

From: Parotid gland shrinkage during IMRT predicts the time to Xerostomia resolution

Characteristic Stratification # pts %
Sex Male 77 90.6
  Female 8 9.4
Primary tumor site Tonsil 37 43.5
  Base of tongue 46 54.1
  Pharyngeal wall 2 2.4
AJCC stage I 2 2.4
  II 7 8.2
  III 8 9.4
  IV 68 80.0
Smoking at diagnosis No 67 78.8
  Yes 18 21.2
Smoking during follow up No 73 85.9
  Yes 12 14.1
PEG No 17 20.0
  Yes 68 80.0
Px dose to PTV1 68.25 Gy 5 5.9
  70 Gy 80 94.1
Chemotherapy Concomitant (Platin-based) 63 74.1
  Induction + Concomitant 7 8.2
  Cetuximab 5 5.9
  None 10 11.8